By Sasha Stafford | Principal Scientist & Founder | Prodelic Technologies LLC For decades, the standard in clinical psychedelic research has been relatively uniform: administer a synthetic pill of psilocybin, wait for the patient's liver to metabolize it, and guide them through the resulting hours-long experience. Psilocybin has become the undisputed poster child of the psychedelic renaissance. However, a groundbreaking new study recently published in the Journal of Psychopha